Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

MIND diet linked to lower risk of dementia across diverse populations

As the U.S. population ages and dementia cases rise, many people are asking whether it is possible to prevent this devastating disease.

3 Jun 2025

Older adults accurately gauge their financial skills until dementia sets in

Older adults are quite aware of their financial abilities – and these abilities actually improve with age – that is, until dementia sets in, according to new research from Binghamton University, State University of New York.

2 Jun 2025

Molecular stress makes old neurons vulnerable to neurodegenerative diseases

As the global population ages, the risk of developing neurodegenerative diseases such as dementia, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) continues to rise. But the molecular mechanisms behind the deterioration of brain cells have remained elusive.

2 Jun 2025

New discovery reveals immune molecule’s role in Alzheimer’s disease

A new way of thinking about Alzheimer's disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer's and other neurodegenerative diseases.

2 Jun 2025

Epileptic seizures more common in frontotemporal dementia patients than previously known

According to a recent study, in patients with frontotemporal dementia (FTD), epileptic seizures are significantly more common than previously known.

2 Jun 2025

New wearable device monitors brain waste clearance during sleep

A new device that monitors the waste-removal system of the brain may help to prevent Alzheimer's and other neurological diseases, according to a study published today in Nature Biomedical Engineering.

31 May 2025

Research uncovers new links between blood lipid profiles and risk of developing Alzheimer's

People who are at higher risk for heart disease also seem more likely to develop dementia.

30 May 2025

Sleep disorders predict dementia risk years before diagnosis, study shows

Researchers analyzed health records from over 1 million people in Finland, Wales, and the UK to assess the long-term impact of sleep disorders on neurodegenerative diseases. They found that diagnosed sleep disorders can predict Alzheimer’s, Parkinson’s, and dementia risk up to 15 years before symptoms, regardless of genetic predisposition.

28 May 2025

Decade-long brain study offers new insights into aging

Researchers from The University of Texas at Dallas' Center for Vital Longevity (CVL) have released the full dataset from a decade-long project designed to track brain and cognitive health as people age and distinguish neurologically healthy paths from those indicating a likelihood of decline.

28 May 2025

Study highlights barriers to Alzheimer’s care in rural Georgia

Rural Georgians may find it difficult to access medication that could slow the progression of Alzheimer's disease, according to a new study from the University of Georgia.

28 May 2025

Traditional South Asian medicinal plants show promise in addressing memory disorders

The growing global population of elderly individuals has led to a dramatic rise in chronic diseases, including neurocognitive disorders such as Alzheimer's disease.

27 May 2025

Alzheimer’s blood biomarkers predict faster muscle strength loss in older adults

A large Swedish cohort study found that elevated blood biomarkers associated with Alzheimer’s disease—including p-tau217, p-tau181, neurofilament light chain, and GFAP—predict accelerated muscle strength decline over 12 years in dementia-free older adults. These findings suggest that early identification of Alzheimer’s-related biomarkers could help clinicians intervene sooner to prevent sarcopenia and related adverse outcomes in aging populations.

27 May 2025

Blood test pinpoints early Alzheimer’s risk with high accuracy

Researchers evaluated a fully automated plasma biomarker panel to detect early amyloid-β accumulation in cognitively unimpaired adults at risk for Alzheimer’s disease. Plasma p-tau217/Aβ42 emerged as the most robust and accurate blood-based marker for identifying preclinical amyloid pathology.

26 May 2025

Study uncovers new molecular mechanisms linked to Alzheimer's cognitive decline

A research team at the University of Barcelona's Institute of Neurosciences (UBneuro) has discovered new molecular mechanisms related to the cognitive decline associated with Alzheimer's disease, the most common dementia.

26 May 2025

Insulin resistance in the brain may link Alzheimer’s and epilepsy

Researchers at the University of São Paulo (USP) in Brazil have succeeded in showing, in an animal model, that the process of insulin resistance in the brain affects both Alzheimer's disease and epilepsy and may be a linking factor between the two diseases.

22 May 2025

New gene delivery systems can reach cells in the brain and spinal cord with exceptional accuracy

Research teams funded by the National Institutes of Health (NIH) have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord with exceptional accuracy.

21 May 2025

Herpes virus infection linked to higher Alzheimer’s risk, study shows antiherpetic drugs may help

A large US case-control study found that people diagnosed with herpes simplex virus type 1 (HSV-1) had a higher risk of developing Alzheimer’s disease. Use of antiherpetic medications was associated with a reduced risk of Alzheimer’s in those with HSV-1.

21 May 2025

New Alzheimer's drug candidate reduces toxic protein and improves memory in mice models

As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the disease and improved memory in mice by boosting production of a protective protein.

20 May 2025

MIT researchers discover new potential drug targets for Alzheimer’s disease

By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer's disease.

20 May 2025

Headway in Alzheimer’s disease care: New guidance provides recommendations for use of anti-amyloid monoclonal antibodies

The new guidelines for the use of monoclonal antibodies (mAbs) published in Neurodegenerative Diseases, serve as exemplary clinical recommendations for clinicians and healthcare providers, supporting the advancement of Alzheimer's disease treatment in Switzerland.

From S. Karger AG 19 May 2025

Alzheimer's Disease News and Research

Further Reading

MIND diet linked to lower risk of dementia across diverse populations

Older adults accurately gauge their financial skills until dementia sets in

Molecular stress makes old neurons vulnerable to neurodegenerative diseases

New discovery reveals immune molecule’s role in Alzheimer’s disease

Epileptic seizures more common in frontotemporal dementia patients than previously known

New wearable device monitors brain waste clearance during sleep

Research uncovers new links between blood lipid profiles and risk of developing Alzheimer's

Sleep disorders predict dementia risk years before diagnosis, study shows

Decade-long brain study offers new insights into aging

Study highlights barriers to Alzheimer’s care in rural Georgia

Traditional South Asian medicinal plants show promise in addressing memory disorders

Alzheimer’s blood biomarkers predict faster muscle strength loss in older adults

Blood test pinpoints early Alzheimer’s risk with high accuracy

Study uncovers new molecular mechanisms linked to Alzheimer's cognitive decline

Insulin resistance in the brain may link Alzheimer’s and epilepsy

New gene delivery systems can reach cells in the brain and spinal cord with exceptional accuracy

Herpes virus infection linked to higher Alzheimer’s risk, study shows antiherpetic drugs may help

New Alzheimer's drug candidate reduces toxic protein and improves memory in mice models

MIT researchers discover new potential drug targets for Alzheimer’s disease

Headway in Alzheimer’s disease care: New guidance provides recommendations for use of anti-amyloid monoclonal antibodies

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News